Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals

R. J. Brüggemann; D. J.A.R. Moes; K. P. van Rhee; N. E. van 't Veer; B. C.P. Koch; M. van Rossum; A. Vermeulen Windsant - van den Tweel; M. H.E. Reijers; R. R.J. van Kimmenade; J. C. Rahamat-Langedoen; T. C.D. Rettig; R. van Raalte; J. van Paassen; F. N. Polderman; P. D. van der Linden; T. Frenzel; Q. de Mast; D. M. Burger; J. Schouten; F. L. van de Veerdonk; P. Pickkers; R. ter Heine

Article

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals

International Journal of Antimicrobial Agents

DOI: 10.1016/j.ijantimicag.2021.106293

1Citations

23Readers

Get full text

Cite

CITATION STYLE

APA

Brüggemann, R. J., Moes, D. J. A. R., van Rhee, K. P., van ’t Veer, N. E., Koch, B. C. P., van Rossum, M., … ter Heine, R. (2021, March 1). Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals. International Journal of Antimicrobial Agents. Elsevier B.V. https://doi.org/10.1016/j.ijantimicag.2021.106293

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals

Cite

Register to see more suggestions